KNSA - Balance Sheet - Kiniksa Pharmaceuticals, Ltd.

Current Liabilities	101 M
Accounts Payable	2.04 M
Short-Term Debt	1.99 M
Other Current Liabilities	96.6 M
Non-Current Liabilities	41.5 M
Long-Term Debt	0
Other Non-Current Liabilities	41.5 M

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018	Dec-2017	Dec-2016
ASSETS
Cash & Cash Equivalents	183.6	108.0	122.7	122.5	114.0	46.9	307.3	45.6	56.0
Short Term Investments	60.0	98.4	67.9	59.7	209.4	186.5	235.3	0	0
Receivables	41.7	21.3	20.3	4.0	0	0	0	0	0
Inventory	26.4	31.1	21.6	3.7	0	0	0	0	0
Other Current Assets	20.1	17.5	10.5	13.2	9.8	16.5	12.9	1.5	0.4
Total Current Assets	331.8	276.3	243.1	196.4	333.2	241.6	313.8	47.1	56.3
PP&E	11.0	12.7	7.0	8.4	10.6	8.3	6.4	0.1	84 K
Intangible Assets	16.2	17.2	18.2	19.2	0	0	0	0	0
Goodwill	0	0	0	0	0	0	0	0	0
Long Term Investments	0	0	0	0	0	0.2	0.2	0	0
Other Long Term Assets	10.3	0.8	5.8	8.7	5.6	0.2	0.6	25 K	8 K
Other Assets	0	0	0	0	0	0	0	0	0
Total Assets	580.6	526.3	459.7	232.8	349.5	254.5	322.0	47.5	56.5
LIABILITIES
Accounts Payable	2.0	8.2	7.9	1.9	0.5	5.7	10.9	1.2	0.2
Short Term Debt	2.0	2.3	6.6	6.8	4.2	3.4	0	0	0
Other Current Liabilities	96.6	52.9	32.6	36.2	27.1	18.7	31.6	16.2	2.1
Total Current Liabilities	100.6	63.7	47.1	44.8	31.8	27.8	42.6	17.4	2.3
Long Term Debt	0	10.0	2.6	2.7	4.9	1.0	0	0	0
Deferred Tax Income	0	0	0	0	0	0	1.2	0	0
Other Liabilities	41.5	1.9	1.8	0.3	0.8	0.3	0.1	119.8	79.9
Total Liabilities	142.1	87.5	63.5	47.8	37.5	29.1	42.7	137.2	82.2
EQUITY
Common Stock	20 K	20 K	19 K	18 K	18 K	15 K	13 K	1 K	1 K
Retained Earnings	(521.1)	(477.9)	(492.0)	(675.4)	(517.5)	(356.1)	(194.2)	(91.0)	(26.1)
Other Accumulative Comprehensive Income/Loss	(0.2)	6 K	44 K	66 K	34 K	33 K	4 K	52 K	24 K
Total Equity	438.4	438.8	(492.0)	(675.4)	(517.5)	(356.1)	(194.2)	(89.7)	(25.7)
Total Liabilities and Equity	580.6	526.3	(428.5)	(627.6)	(479.9)	(327.0)	(151.5)	47.5	56.5
SHARES OUTSTANDING
Common Shares Outstanding	71.4	70.1	69.4	68.6	61.8	54.0	29.5	32.5	32.5

Free